These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9033655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC, Quax PH, Löwik CW, Verheijen JH.
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R, Torà M, Díaz VM, Real FX.
    Oncogene; 1998 Feb 05; 16(5):625-33. PubMed ID: 9482108
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 05; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
    Sappino AP, Huarte J, Belin D, Vassalli JD.
    J Cell Biol; 1989 Nov 05; 109(5):2471-9. PubMed ID: 2509486
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasminogen activators and cancer.
    Duffy MJ.
    Blood Coagul Fibrinolysis; 1990 Dec 05; 1(6):681-7. PubMed ID: 2133247
    [Abstract] [Full Text] [Related]

  • 15. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.
    Reiter LS, Kruithof EK, Cajot JF, Sordat B.
    Int J Cancer; 1993 Feb 01; 53(3):444-50. PubMed ID: 8381394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 18. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
    Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA.
    Cancer Res; 1999 Mar 15; 59(6):1327-36. PubMed ID: 10096567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T, Toet K, Quax P, Kooistra T.
    Kidney Int; 1999 Jan 15; 55(1):120-9. PubMed ID: 9893120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.